Literature DB >> 10971169

High frequency of metastatic Leydig cell testicular tumours.

L M Farkas1, J G Székely, C Pusztai, M Baki.   

Abstract

690 patients were treated for testicular tumour in the course of 18 years. The histology of 7 cases showed Leydig cell tumour. In 4 of the 7 cases, a metastatic process leading to death was observed. At the time of diagnosis, 5 patients were found to have low stage, whereas 2 of the patients had advanced lymphatic involvement. The hematogenous and lymphatic metastases proved to be resistant to chemotherapy. Contrary to the major part of the literature, retroperitoneal lymphadenectomy should be performed with this histological type for the exact pathological staging immediately following orchiectomy. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971169     DOI: 10.1159/000012147

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  16 in total

Review 1.  Management of non-germinal testicular tumors.

Authors:  Michael C Risk; Christopher R Porter
Journal:  World J Urol       Date:  2009-03-26       Impact factor: 4.226

Review 2.  The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms).

Authors:  Robert R Maronpot; Abraham Nyska; Jennifer E Foreman; Yuval Ramot
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

3.  Testicle-sparing surgery versus radical orchiectomy in the management of Leydig cell tumors: results from a multicenter study.

Authors:  Florian Laclergerie; Guillaume Mouillet; Alexandre Frontczak; Loïc Balssa; Pascal Eschwege; Christian Saussine; Stéphane Larré; Luc Cormier; Antoine Thiery Vuillemin; François Kleinclauss
Journal:  World J Urol       Date:  2017-12-11       Impact factor: 4.226

4.  The natural history of Leydig cell testicular tumours: an analysis of the National Cancer Registry.

Authors:  G J Nason; E J Redmond; S W Considine; S I Omer; D Power; P Sweeney
Journal:  Ir J Med Sci       Date:  2017-07-19       Impact factor: 1.568

5.  A contemporary population-based study of testicular sex cord stromal tumours: Presentation, treatment patterns, and predictors of outcome.

Authors:  Lindsay M Yuh; Primo N Lara; Rebecca M Wagenaar; Christopher P Evans; Marc A Dall'era; Rosemary Cress; Stanley A Yap
Journal:  Can Urol Assoc J       Date:  2017-09       Impact factor: 1.862

6.  Colour Doppler and ultrasound characteristics of testicular Leydig cell tumours.

Authors:  Florian Maxwell; Vincent Izard; Sophie Ferlicot; Antoine Rachas; Jean-Michel Correas; Gérard Benoit; Marie-France Bellin; Laurence Rocher
Journal:  Br J Radiol       Date:  2016-04-13       Impact factor: 3.039

7.  Leydig Cell Tumor Associated with Testicular Adrenal Rest Tumors in a Patient with Congenital Adrenal Hyperplasia due to 11β-Hydroxylase Deficiency.

Authors:  Nadia Charfi; Mahdi Kamoun; Mouna Feki Mnif; Neila Mseddi; Fatma Mnif; Nozha Kallel; Basma Ben Naceur; Nabila Rekik; Hela Fourati; Emna Daoud; Zainab Mnif; Mourad Hadj Sliman; Tahia Sellami-Boudawara; Mohamed Abid
Journal:  Case Rep Urol       Date:  2012-02-12

8.  Precocious puberty related to Leydig cell testicular tumor: the diagnostic imaging keys.

Authors:  Téodor Grand; Anne-Laure Hermann; Maxime Gérard; Emmanuel Arama; Linda Ouerd; Nada Garrouche; Laurence Rocher
Journal:  Eur J Med Res       Date:  2022-05-12       Impact factor: 4.981

Review 9.  Leydig cell tumor in a patient with 49,XXXXY karyotype: a review of literature.

Authors:  Salwan Maqdasy; Laura Bogenmann; Marie Batisse-Lignier; Béatrice Roche; Fréderic Franck; Françoise Desbiez; Igor Tauveron
Journal:  Reprod Biol Endocrinol       Date:  2015-07-10       Impact factor: 5.211

10.  Retroperitoneal lymph node dissection (RPLND) for malignant phenotype Leydig cell tumours of the testis: a 10-year experience.

Authors:  Jane Hendry; Sioban Fraser; Jeff White; Prabhakar Rajan; David S Hendry
Journal:  Springerplus       Date:  2015-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.